Search results for “T cell repertoire” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 51 patents, we discovered top 14 key players by total patent application. Oncolytics Biotech, Inc., NexImmune, Inc., Helmholtz Zentrum München are dominant in this area. They take 47.06% of the total patent filing.
Oncolytics Biotech, Inc.
Alberta, Canada
Patent: 9
NexImmune, Inc.
United States
Patent: 8
Helmholtz Zentrum München
Germany
Patent: 7
Adaptive Biotechnologies Corp.
Washington, United States
Patent: 6
Resolution Bioscience, Inc.
Washington, United States
Patent: 4
Infinant Health, Inc.
California, United States
Patent: 2
Ciba-Geigy AG
Switzerland
Patent: 1
The Broad Institute, Inc.
Massachusetts, United States
Patent: 1
The General Hospital Corp.
Massachusetts, United States
Patent: 1
The University of Georgia Research Foundation, Inc.
Georgia, United States
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 27 patents applied in the last 5 years. We discover 8 most active companies in this area. The fast-growing Oncolytics Biotech, Inc., NexImmune, Inc., Resolution Bioscience, Inc. take 77.78% of patent filing during this period.
Oncolytics Biotech, Inc.
Alberta, Canada
Patent: 9
NexImmune, Inc.
United States
Patent: 8
Resolution Bioscience, Inc.
Washington, United States
Patent: 4
Infinant Health, Inc.
California, United States
Patent: 2
IDAC Theranostics, Inc.
Tokyo-to, Japan
Patent: 1
The University of Georgia Research Foundation, Inc.
Georgia, United States
Patent: 1
National Cancer Center Korea
Gyeonggi-do, South Korea
Patent: 1
University of Tokyo
Tokyo-to, Japan
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 27 patents in last 5 years, we discover 8 new entrants. Oncolytics Biotech, Inc., NexImmune, Inc., Resolution Bioscience, Inc. are the most active new entrants in this area.
Oncolytics Biotech, Inc.
Alberta, Canada
Patent: 9
NexImmune, Inc.
United States
Patent: 8
Resolution Bioscience, Inc.
Washington, United States
Patent: 4
Infinant Health, Inc.
California, United States
Patent: 2
IDAC Theranostics, Inc.
Tokyo-to, Japan
Patent: 1
The University of Georgia Research Foundation, Inc.
Georgia, United States
Patent: 1
National Cancer Center Korea
Gyeonggi-do, South Korea
Patent: 1
University of Tokyo
Tokyo-to, Japan
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 44 patents, we discovered top 6 universities and scientific research institutions by total patent application. Statens Serum Institute, Yale University, Case Western Reserve University are dominant in this area. They take 59.09% of the total patent filing.
Statens Serum Institute
Denmark
Patent: 13
Yale University
Connecticut, United States
Patent: 7
Case Western Reserve University
Ohio, United States
Patent: 2
Charité - Universitätsmedizin Berlin
Berlin, Germany
Patent: 2
University of Tokyo
Tokyo-to, Japan
Patent: 1
University of Seville
Spain
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: